[ad_1]
Zheng, Y. et al. Associations of weight gain from early to middle adulthood with major health outcomes later in life. JAMA 318, 255–259 (2017).
Wing, R. & Phelan, S. Long-term weight maintenance. Am. J. Clin. Nutr. 82, 222S–225S (2005).
Phelan, S. & Wing, R. Prevalance of successful weight loss. Arch. Int. Med. 165, 2430 (2005).
Aronne, L. et al. Describing the weight-reduced state: physiology, behavior, and interventions. Obesity 29, S9–S24 (2021).
Rosenbaum, M. & Leibel, R. in Treatment of the Obese Patient 2nd edn (eds. R. Kushner & D. Bessesen) Ch. 7 (Springer, 2014).
Unick, J. et al. Effectiveness of lifestyle interventions for individuals with severe obesity and type 2 diabetes: results from the Look AHEAD trial. Diabetes Care 34, 2152–2157 (2011).
Wadden, T. et al. The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity 14, 737–752 (2006).
Sjostrom, L. et al. Effects of bariatric surgery on mortality in swedish obese subjects. N. Eng. J. Med. 357, 741–752 (2007).
Sacks, F. et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N. Eng. J. Med. 360, 859–873 (2009).
Unick, J. et al. The long-term effectiveness of a lifestyle intervention in severely obese individuals. Am. J. Med. 126, 236–242 (2013).
Stanford, F. et al. Comparison of short and long-term outcomes of metabolic and bariatric surgery in adolescents and adults. Front. Endocrinol. 11, 157 (2020).
Tchang, B. G., Aras, M., Kumar, R. B. & Aronne, L. J. in Endotext (ed. K. Feingold) (MDText.com, 2021).
The Look AHEAD Research Group. The Look AHEAD Study: a description of the lifestyle intervention and the evidence supporting it. Obesity 14, 737–752 (2006).
Garvey, W. et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat. Med. 28, 2083–2091 (2022).
Guo, J., Brager, D. & Hall, K. Simulating long-term human weight-loss dynamics in response to caloric restriction. Am. J. Clin. Nutr. 107, 558–565 (2018).
Hall, K. et al. Quantificaiton of the effect of energy imbalance on bodyweight. Lancet 378, 826–837 (2011).
Hall, K., Sanghvi, A. & Gobel, B. Proportional feedback control of energy intake during obesity pharmacotherapy. Obesity 25, 2088–2091 (2017).
Ford, E. & Dietz, W. Trends in energy intake among adults in the United States: findings from NHANES. Am. J. Clin. Nutr. 97, 848–853 (2013).
Lewontin, R. The analysis of variance and the analysis of causes. Int. J. Epidemiol. 35, 520–525 (2006).
Ogden, C. et al. Trends in obesity prevalence by race and hispanic origin-1999–2000 to 2017–2018. JAMA 324, 1208–1210 (2020).
Koethe, J. R. et al. Rising obesity prevalence and weight gain among adults starting antiretroviral therapy in the United States and Canada. AIDS Res. Hum. Retroviruses 32, 50–58 (2016).
Rosenbaum, M. & Leibel, R. in Novel Insights into Adipose Cell Functions, Research and Perspectives in Endocrine Interactions (eds. Y. Christen & K. Clément) 121–133 (Springer, 2010).
Hall, K. & Kahan, S. Maintenance of lost weight and long-term management of obesity. Med. Clin. North Am. 102, 183–197 (2018).
Thomas, J., Bond, D., Phelan, S., Hill, J. & Wing, R. Weight-loss maintenance for 10 years in the National Weight Control Registry. Am. J. Prev. Med. 46, 17–23 (2014).
Phelan, S., Halfman, T., Pinto, A. & Foster, G. Behavioral and psychological strategies of long-term weight loss maintainers in a widely available weight management program. Obesity 28, 421–428 (2020).
Rosenbaum, M. & Leibel, R. 20 years of leptin: role of leptin in energy homeostasis in humans. J. Endocrinol. 223, T83–T96 (2014).
Rosenbaum, M., Hirsch, J., Murphy, E. & Leibel, R. The effects of changes in body weight on carbohydrate metabolism, catecholamine excretion, and thyroid function. Am. J. Clin. Nutr. 71, 1421–1432 (2000).
Munzberg, H., Laque, A., Yu, S., rezai-Zadeh, K. & Berthoud, H. Appetite and body weight regulation after bariatric surgery. Obes. Rev. 16, 77–90 (2015).
Das, S. et al. Long-term changes in energy expenditure and body composition after massive weight loss induced by gastric bypass surgery. Am. J. Clin. Nutr. 78, 28–30 (2003).
Loos, R., Burant, C. & Schur, E. Strategies to understand the weight-reduced state: genetics and brain imaging. Obesity 29, S39–S50 (2021).
Elder, S. et al. Effect of body composition methodology on heritability estimation of body fatness. Open Nutr. J. 5, 48–58 (2012).
Khera, A. V. et al. Polygenic prediction of weight and obesity trajectories from birth to adulthood. Cell 177, 587–596 (2019).
Unick, J. et al. Weight change in the first 2 months of a lifestyle intervention predicts weight changes 8 years later. Obesity 23, 1353–1356 (2015).
Tronieri, S. et al. Early weight loss in behavioral treatment predicts later rate of weight loss and response to pharmacotherapy. Ann. Behav. Med. 53, 290–295 (2019).
Turicchi, J. et al. Associations between the proportion of fat-free mass loss during weight loss, changes in appetite, and subsequent weight change: results from a randomized 2-stage dietary intervention trial. Am. J. Clin. Nutr. 111, 536–544 (2020).
Martins, C., Gower, G., Hill, J. & Hunter, G. Metabolic adaptation is not a major barrier to weight-loss maintenance. Am. J. Clin. Nutr. 112, 558–565 (2020).
Thom, G. et al. The role of appetite-related hormones, adaptive thermogenesis, perceived hunger and stress in long-term weight-loss maintenance: a mixed-methods study. Eur. J. Clin. Nutr. 74, 622–632 (2020).
Dietz, W. & Pryor, S. How can we act to mitigate the global syndemic of obesity, undernutrition, and climate change? Curr. Obes. Rep. 11, 61–69 (2022).
Pryor, S. & Dietz, W. The COVID-19, obesity, and food insecurity syndemic. Curr. Obes. Rep. 11, 70–79 (2022).
Newton, S., Braithwaite, D. & Akinyemiju, T. Socio-economic status over the life course and obesity: systematic review and meta-analysis. PLoS ONE 15, e0177151 (2017).
Moore, C. & Cunningham, S. Social position, psychological stress, and obesity: a systematic review. J. Acad. Nutr. Diet. 112, 418–426 (2012).
Heymsfield, S., van Mierlo, C., van der Knaap, H., Heo, M. & Frier, H. Weight management using a meal replacement strategy: meta and pooling analysis from six studies. Int. J. Obes. Relat. Metab. Disord. 27, 547–549 (2003).
Astbury, N. et al. A systematic review and meta-analysis of the effectiveness of meal replacements for weight loss. Obes. Rev. 20, 569–587 (2019).
Varkevisser, R., Van Stralen, M., Kroeze, W., Ket, J. & Stenhuis, I. Determinants of weight loss maintenance: a systematic review. Obes. Rev. 20, 171–211 (2019).
Fitzgibbon, M. et al. Weight loss and African-American women: a systematic review of the behavioural weight loss intervention literature. Obes. Rev. 13, 192–213 (2012).
Wingo, B. & Ard, T. C. J. Weight loss differences by race. Obes. Rev. 15, 46–61 (2014).
West, D. et al. Weight loss experiences of African American, Hispanic, and Non-Hispanic white men and women with type 2 diabetes: the Look AHEAD trial. Obes 27, 1275–1284 (2019).
The Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle intervention: the Look AHEAD study. Obesity 22, 5–13 (2014).
Kinsey, A. et al. Factors associated with weight loss maintenance and weight regain among african american and white adults initially successful at weight loss. J. Racial Ethn. Health Disparities 9, 546–565 (2022).
Reyes, N. et al. Similarities and differences between weight loss maintainers and regainers: a qualitative analysis. J. Acad. Nutr. Diet. 112, 449–505 (2012).
Bergman, N., Davies, M., Lingvay, I., Knop, F. Semaglutide for the treatment of overweight and obesity: a review. Diab. Obes. Metab. https://doi.org/10.1111/dom.14863. (2022).
Jastrebogg, A. et al. Tirzepatide once weekly for the treatment of obesity. N. Eng. J. Med. 387, 205–216 (2022).
Hollander, P. et al. Coadministration of canagliflozin and phentermine for weight management in overweight and obese individuals without diabetes: a randomized clinical trial. Diabetes Care 40, 632–639 (2017).
Tronieri, J. et al. Effects of liraglutide plus phentermine in adults with obesity following 1 year of treatment by liraglutide alone: a randomized placebo-controlled pilot trial. Metabolism 96, 83–91 (2019).
Farooqi, I. et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N. Eng. J. Med. 341, 879–884 (1999).
Heymsfield, S. B. et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 292, 1568–1575 (1999).
Rosenbaum, M. et al. Effects of weight change on plasma leptin concentrations and energy expenditure. J. Clin. Endocrinol. Metab. 82, 3647–3654 (1997).
Hukshom, C. et al. The effect of pegylated recombinant human leptin (PEG-OB) on weight loss and inflammatory status in obese subjects. Int. J. Obes. 26, 504–509 (2002).
Hukshorn, C., Meneheere, P., Westerterp-Plantenga, M. & Saris, W. The effect of pegylated human recombinant leptin (PEG-OB) on neuroendocrine adaptations to semi-starvation in overweight men. Eur. J. Endocrinol. 148, 649–655 (2003).
Lejeune, M., Hukshorn, C., Saris, W. & Westerterp-Plantenga, M. Effect of dietary restraint during and following pegylated recombinant leptin (PEG-OB) treatment of overweight men. Int. J. Obes. 27, 1494–1499 (2003).
Saris, C. H. W., Westerterp-Plantenga, M., Farid, A., Smith, F. & Campfield, L. Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men. J. Clin. Endocrinol. Metab. 85, 4003–4009 (2000).
Rosenbaum, M. et al. Low dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J. Clin. Invest. 115, 3579–3586 (2005).
Rosenbaum, M., Sy, M., Pavlovich, K., Leibel, R. & Hirsch, J. Leptin reverses weight loss–induced changes in regional neural activity responses to visual food stimuli. J. Clin. Invest. 118, 2583–2591 (2008).
Rosenbaum, M. et al. Triiodothyronine and leptin repletion in humans similarly reverse weight-loss induced changes in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 315, E771–E779 (2018).
Wadden, T., Butryn, M. & Byrne, K. Efficacy of lifestyle modification for long-term weight control. Obes. Res. 12, 151S–162S (2004).
Bryant, D. T. L. L. M. et al. Efficacy of a commercial weight management program compared with a do-it-yourself approach: a randomized clinical trial. JAMA Netw. Open. 5, e2226561 (2022).
Hayes, J. et al. Recovery from weight regain among long-term weight loss maintainers in WW. Obesity 30, 2404–2413 (2022).
Wadden, T. et al. Four-year weight losses in the Look AHEAD study: factors associated with long-term success. Obesity 19, 1987–1998 (2011).
Wadden, T., Tronieri, J. & Butrybn, M. Lifestyle modification approaches for the treatment of obesity in adults. Am. Psychol. 75, 235–251 (2020).
Cornelius, T. et al. How prescriptive support affects weight loss in weight-loss intervention participants and their untreated spouses. Health Psychol. 37, 775–781 (2018).
Gudzune, K. et al. Efficacy of commercial weight-loss programs: an updated systematic review. Ann. Intern. Med. 162, 501–512 (2015).
Curion, C. & Lourenc, P. Long-term weight loss after diet and exercise: a systematic review. Int. J. Obes. 29, 1168–1174 (2005).
Donnelly, J. et al. American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med. Sci. Sports Exerc. 41, 459–471 (2009).
Ai, X., Yang, J., Lin, Z. & Wan, X. Mental health and the role of physical activity during the COVID-19 pandemic. Front. Psychol. 12, 759987 (2021).
van Baak, M., Hul, G., Astrup, A. & Saris, W. Physical activity, weight loss, and weight maintenance in the DiOGenes Multicenter Trial. Front Nutr. 8, 683369 (2021).
Wang, X. et al. Weight regain is related to decreases in physical activity during weight loss. Med. Sci. Sports Exerc. 40, 1781–1788 (2008).
Wing, R., Tate, D., Gorin, A., Raynor, H. & Fava, J. A self-regulation program for maintenance of weight loss. N. Eng. J. Med. 355, 1563–1571 (2006).
Yancy, W. Jr et al. Effect of escalating financial incentive rewards on maintenance of weight loss: a randomized clinical trial. JAMA Netw. Open. 2, e1914393 (2019).
Yancy, W. Jr et al. Financial incentive strategies for maintenance of weight loss: results from an internet-based randomized controlled trial. Nutr. Diabetes 8, 33 (2021).
Flore, G. et al. Weight maintenance after dietary weight loss: systematic review and meta-analysis on the effectiveness of behavioural intensive intervention. Nutrients 14, 1259 (2022).
Sumithran, P. & Proietto, J. The defence of body weight: a physiological basis for weight regain after weight loss. Clin. Sci. 124, 231–241 (2013).
Sumithran, P. et al. Long-term persistance of hormonal adaptations to weight loss. N. Eng. J. Med. 365, 1597–1604 (2011).
Salem, V. et al. Weight loss by low-calorie diet versus gastric bypass surgery in people with diabetes results in divergent brain activation patterns: a functional MRI Study. Diabetes Care. 44, 1842–1851 (2021).
Delahanty, L. et al. Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program. Diabetes Care 35, 363–366 (2012).
McCaffery, J. et al. FTO predicts weight regain in the Look AHEAD clinical trial. Int. J. Obes. 37, 1545–1552 (2013).
Papandonatos, G. et al. Genetic predisposition to weight loss and regain with lifestyle intervention: analyses from the Diabetes Prevention Program and the Look AHEAD randomized controlled trials. Diabetes 64, 4312–4321 (2015).
Larsen, L. et al. Analyses of single nucleotide polymorphisms in selected nutrient-sensitive genes in weight-regain prevention: the DiOGenes study. Am. J. Clin. Nutr. 95, 1254–1260 (2012).
Batra, P. et al. Eating behaviors as predictors of weight loss in a 6-month weight loss intervention. Obesity 21, 2256–2263 (2013).
Womble, L., Williamson, D., Greenway, F. & Redmann, S. Psychological and behavioral predictors of weight loss during drug treatment for obesity. Int. J. Obes. 25, 340–345 (2001).
Vogels, N., Diepvens, K. & Westerterp-Plantenga, M. Predictors of long-term weight maintenance. Obes. Res. 13, 2162–2168 (2005).
Munro, I., Bore, M., Nunro, D. & Garg, M. Using personality as a predictor of diet induced weight loss and weight management. Int J. Behav. Nutr. Phys. Act. 8, 129 (2011).
Price, D. et al. Depression as a predictor of weight regain among successful weight losers in the diabetes prevention program. Diabetes Care 36, 216–221 (2013).
Labayen, I. et al. Role of baseline leptin and ghrelin levels on body weight and fat mass changes after an energy-restricted diet intervention in obese women: effects on energy metabolism. J. Clin. Endocrinol. Metab. 96, E996–E1000 (2011).
Shih, L. et al. Leptin, superoxide dismutase, and weight loss: initial leptin predicts weight loss. Obesity 14, 2184–2192 (2006).
Wang, P. et al. Circulating ACE is a predictor of weight loss maintenance not only in overweight and obese women, but also in men. Int. J. Obes. 36, 1545–1551 (2012).
Hansen, D. et al. Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. Sibutramine Trial of Obesity Reduction and Maintenance. Int. J. Obes. 25, 496–501 (2001).
Foster, G. et al. The Eating Inventory in obese women: clinical correlates and relationship to weight loss. Int. J. Obes. 22, 778–785 (1998).
Stunkard, A. et al. Weight change in depression: influence of ‘disinhibition’ is mediated by body mass and other variables. Psychiatr. Res. 38, 197–200 (1991).
Wolters, B., Lass, N. & Reinehr, T. TSH and free triiodothyronine concentrations are associated with weight loss in a lifestyle intervention and weight regain afterwards in obese children. Eur. J. Endocrinol. 168, 323–329 (2013).
Leibel, R., Rosenbaum, M. & Hirsch, J. Changes in energy expenditure resulting from altered body weight. N. Eng. J. Med. 332, 621–628 (1995).
Rosenbaum, M., Hirsch, J., Gallagher, D. & Leibel, R. Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight. Am. J. Clin. Nutr. 88, 906–912 (2008).
Goldsmith, R. et al. Effects of experimental weight perturbation on skeletal muscle work efficiency, fuel utilization, and biochemistry in human subjects. Am. J. Physiol. 298, R79–R88 (2010).
Kissileff, H. et al. Leptin reverses decline in satiation in weight-reduced obese individuals. Am. J. Clin. Nutr. 95, 309–317 (2012).
Rosenbaum, M. & Leibel, R. L. Models of energy homeostasis in response to maintenance of reduced body weight. Obesity 24, 1620–1629 (2016).
Unick, J., Pellegrini, C., Demose, K. & Dorfman, L. Initial weight loss response as an indicator for provding early rescue efforts to improve long-term treatment outcomes. Curr. Diab Rep. 17, 69 (2018).
Dong, Z., Xu, L., Liu, H., Lv, Y. & Li, L. Comparative efficacy of five long-term weight loss drugs: quantitative information for medication guidelines. Obes. Rev. 18, 1377–1385 (2017).
Wadden, T., Webb, V., Moran, C. & Bailer, B. Lifestyle modification for obesity. Circulation 125, 1157–1170 (2012).
Smith, S. et al. Multicenter, placebo-controlled trial of lorcaserin for weight management. N. Eng. J. Med. 363, 245–256 (2010).
[ad_2]
Source link
